Skip Navigation
Skip to contents

KDDW 2021


Invited Speakers

Home    >    Program    >    Invited Speakers

Member Societies

검색
  • * Bookmark: To add speakers to your Favorites, log in and click 'Star.' Your Favorites List can be found on My Page.

KASL-AASLD Joint Symposium 01 (KASL) : Nov. 19 (Fri),08:30-10:00
- COVID-19 and the Management of Chronic Liver Diseases

  • Pathogenesis and outcomes of COVID-19 in patients with chronic liver disease Andrew Moon
    Univ. of North Carolina, USA
    CV 즐겨찾기
  • COVID-19 in liver transplantation Elizabeth C. Verna
    Columbia Univ., USA
    CV 즐겨찾기
  • COVID-19 vaccination for patients with chronic liver diseases Won Suk Choi
    Korea Univ., Infectious Diseases, Korea
    CV 즐겨찾기

KASL-AASLD Joint Symposium 02 (KASL) : Nov. 19 (Fri),10:15-11:45
- Recent Update of Fatty Liver Disease

  • A unique phenotype of NAFLD: NAFLD with sarcopenia Won Kim
    Seoul National Univ., Korea
    CV 즐겨찾기
  • Recent updates of clinical trials on NASH Mary Eugenia Rinella
    The Univ. of Chicago, USA
    CV 즐겨찾기
  • Influence of NAFLD on chronic hepatitis B and C Seung Up Kim
    Yonsei Univ., Korea
    CV 즐겨찾기

KASL-AASLD Joint Symposium 03 (KASL) : Nov. 19 (Fri),12:25-13:55
- Changes in the Management of Chronic Hepatitis B

  • Artificial intelligence-driven HCC prediction model for patients with chronic hepatitis B Hwi Young Kim
    Ewha Womans Univ., Korea
    CV 즐겨찾기
  • Expanding treatment criteria for chronic hepatitis B Young-Suk Lim
    Univ. of Ulsan, Korea
    CV 즐겨찾기
  • Recent updates of clinical trials on functional cure of chronic hepatitis B W Ray Kim
    Stanford Univ., USA
    CV 즐겨찾기

Basic/Translational Symposium 04 (KASL) : Nov. 19 (Fri),14:10-15:40
- Basic Science Forum of Liver Disease: Metabolic Approaches for the Translational Medicine of Liver Diseases

  • Small intestinal dietary fructose metabolism prevents non-alcoholic fatty liver disease Cholsoon Jang
    Univ. of California, Irvine, USA
    CV 즐겨찾기
  • Microbial metabolites entering into the liver: The role in diabetes and drug responses Ara Koh
    POSTECH, Korea
    CV 즐겨찾기
  • Fructose modulates leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and Nitrative stress Young-Eun Cho
    Andong National Univ., Food and Nutrition, Korea
    CV 즐겨찾기
  • Role of diabetes on the risk of hepatocellular carcinoma in cirrhosis patients with NAFLD Ju Dong Yang
    Cedars-Sinai Medical Center, USA
    CV 즐겨찾기

Multidisciplinary Session 02 (KASL) : Nov. 19 (Fri),15:55-17:25
- Comprehensive Multidisciplinary Approach for Obesity and/or NAFLD

  • Clinical significance of obese and non-obese Fatty Liver Disease Jeongju Yoo
    Soonchunhyang Univ., Korea
    CV 즐겨찾기
  • Radiological assessment of NAFLD Dong Ho Lee
    Seoul National Univ., Radiology, Korea
    CV 즐겨찾기
  • Endoscopic therapies for obesity in NAFLD Seung-Joo Nam
    Kangwon National Univ., Korea
    CV 즐겨찾기
  • Bariatric surgery in the management of obesity in NAFLD Jong-Han Kim
    Korea Univ., Surgery, Korea
    CV 즐겨찾기


Supported by Member Societies
Associated Society
Sponsored by

Go to Top

  • Copyright© The Korean Society of Gastroenterology. All Rights Reserved.

    Room 305, 31 Seolleung-ro 86 Gil, Gangnam-gu, Seoul, 06193, Korea
  • KDDW 2021 Secretariat [People-x, Inc.]
    1F Haeoreum Bldg., 16, Yeoksam-ro 17 Gil, Gangnam-Gu, Seoul, 06246, Korea
    • Tel. +82-2-566-6031,6032
    • Fax. +82-2-566-6087
    • E-mail. info@kddw.org